The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for JM Travins


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.EBI
TBA
Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists.EBI
Wyeth Pharmaceuticals
1-(3-Aryloxyaryl)benzimidazole sulfones are liver X receptor agonists.EBI
Wyeth Pharmaceuticals
4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists.EBI
Wyeth Pharmaceuticals
Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.EBI
Johnson & Johnson Pharmaceutical Research and Development
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.EBI
Johnson & Johnson Pharmaceutical Research and Development
FUSED IMIDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOFBDB
Jiangsu Hengrui Medicine
Heterocyclic inhibitors of tyrosine kinaseBDB
University Of Texas
Phenyl and pyridinyl substituted imidazoles as modulators of RORγTBDB
Janssen Pharmaceutica
Benzo[b]thiophene compounds as STING agonistsBDB
Merck Sharp & Dohme
Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereofBDB
Universite Paris Descartes
3-Oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitorsBDB
Nerviano Medical Sciences